We hypothesized that the comparison of our patients with anti-FHs aHUS and FHR1 deficiency (cases) with “supercontrols” could allow us detecting genetic variants with clinical value at relatively small sample size. The gene discussed is CFHR1; the disease is hyperinsulinemic hypoglycemia, familial, 4.